---
trial_id: 5
discovery_date: 2022-03-09 19:26:18.158610
date: 2022-03-09 19:26:18.158610
title: "A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis"
summary: |
  <b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Drug: Ocrelizumab<br /><b>Sponsor</b>:    Hoffmann-La Roche<br /><b>Not yet recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05269004?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-03-07 17:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Drug: Ocrelizumab<br /><b>Sponsor</b>:    Hoffmann-La Roche<br /><b>Not yet recruiting</b>